1. Did CMS invalidly apply pre-composite rate ESRD Screens to limit the Provider's reimbursement for the reasonable costs
it incurred for the treatment of ESRD patients?; 2. Whether and to what extent the Provider is entitled to an exception from
the $138 per treatment ESRD screens for fiscal years 2/28/81, 2/28/82, and 2/28/83.